Testosterone products are FDA-approved only for use in men who lack or have low testosterone levels in conjunction with an associated medical condition.
Kansas City, MO (PRWEB) September 30, 2014
The testosterone lawsuit attorneys at Peterson & Associates, P.C. urge patients and doctors to review and follow the recommendations released by the U.S. Food & Drug Administration’s (FDA) testosterone advisory panel on the heart attack and stroke risks posed by testosterone therapy.
According to a Sept. 17, 2014 report from the New York Times, the medical experts on the FDA advisory research panel voted almost unanimously in a 20-1 decision to recommend that testosterone therapy drugs be relabeled. The panel suggested that the new labels clearly indicate that the drugs should not be prescribed to men who are experiencing decreased libidos, exhaustion, or other non-testosterone related complications.
Testosterone therapy is supposed to be used to replace low levels of testosterone in men in order to improve the health effects associated with low levels of testosterone. But the New York Times article noted that millions of prescriptions are written without ever assessing the initial testosterone levels of patients.
The article noted that when testosterone drugs first emerged on the market they were prescribed only to men with serious testosterone deficiencies. A January 2014 safety announcement from the FDA stated “[t]estosterone products are FDA-approved only for use in men who lack or have low testosterone levels in conjunction with an associated medical condition.”
However, the number of American men who take testosterone therapy drugs numbers over 5 million. For the majority of the individuals who are prescribed these drugs, the underlying issues are a function of aging rather than low levels of testerstone. The panel urged the FDA to limit marketing and insurance coverage of testosterone therapy drugs for off-label use.
According to court documents, over 200 federal lawsuits have been filed against the makers of popular testosterone drugs such as AndroGel, Axiron and Testim. (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545).
The lawsuits have been consolidated into a multidistrict litigation proceeding underway in the U.S. District Court, for the Northern District of Illinois (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545).
Peterson & Associates, P.C. attorneys are offering free case evaluations to men who have experienced episodes of cardiac arrest or a stroke incident after being prescribed testosterone supplements. Families who have lost a loved one due to heart attack or stroke after testerone therapy can also request a free legal consultation.
About Peterson & Associates, P.C.
Peterson & Associates, P.C. is an elite personal injury law firm that represents the interests of clients who are injured. The firm’s skilled litigators hold negligent parties responsible when they cause serious accidents and severe injuries.
For decades, the attorneys at Peterson & Associates, P.C., have served clients in and around Kansas City, Missouri resolve all of their personal injury matters. To learn more about the firm’s services visit http://www.petersonlawfirm.com. Individuals interested in contacting the firm to discuss legal issues, may call 1-800-305-7552 or 816-888-8888.